Skip to main content
. 2013 Feb 27;57(1):e10. doi: 10.4081/ejh.2013.e10

Figure 5.

Figure 5

A) Immunohistochemical analysis of BSP expression in Group 1 and Group 2 specimens, respectively. Weak BSP immunolabeling in Group 1 and moderate BSP immunolabeling in Group 2 bone tissue; no BSP immunostaining is seen in negative control. B) Immunohistochemical analysis of SPARC expression, in Group 1 and Group 2 specimens, respectively. Magnification 20×. Group 1: bone tissue specimenss obtained from equinederived bone substitute grafted area; Group 2: bone tissue specimens obtained from calvaria bone grafted area; C(-), negative control. Weak SPARC immunolabeling in Group 1 and moderate SPARC immunolabeling in Group 2 bone tissue; no SPARC immunostaining is seen in negative control. C) Graphic representation of densitometric analysis of BSP and SPARC positive area ± SD determined by direct visual counting of ten fields (mean values) for each of five slides per specimens at 20× magnification (*P<0.001; **P<0.001).